<div dir="auto">I think Kathy and Jeff are right. It is safe to assume that most people will not have read the Framework before going to the session tomorrow.<div dir="auto"><br></div><div dir="auto">Patricio </div></div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">El lun, 12 de jun de 2023, 22:45, Kathy Kleiman <<a href="mailto:Kathy@kathykleiman.com">Kathy@kathykleiman.com</a>> escribió:<br></div><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">
<div>
<p>I'm very much in favor of walking through the Framework a bit, so
I concur with Jeff about posting actual parts of it and even
reading key section to/with the audience. <br>
</p>
<p>Today, in NCSG, I had a few slides. One was the three sections
of the Framework, and then several slides walking through the
substance of each section. I tried to take sections that were
small enough to be readable on screen.</p>
<p>For example, Application Section four (specific the public
interest goal(s)... and Section five (explain the purpose) with
the details of 4a-c, 5a, etc. Of course, Section ten (demonstrate
requirement of representativeness or non-anticompetitive behavior)
with some of the detail.</p>
<p>It raised the level of interest and level of discussion.<font size="2"> <br>
</font></p>
<p><font size="2"><span style="font-size:11pt">Afterwards, of
course, I support Manal's suggestion favoring community
input. <br>
</span></font></p>
<p><font size="2"><span style="font-size:11pt">Best, Kathy<br>
</span></font></p>
On 6/12/2023 6:05 PM, Jeff Neuman wrote:<br>
<blockquote type="cite">
<div dir="ltr">
<div>
<div>I agree 100%. I know many of them will not have read the
framework, so lets post parts up on the screen and open the
floor.</div>
<div id="m_-7181965662703677245ms-outlook-mobile-signature">
<div><br>
</div>
Get <a href="https://aka.ms/o0ukef" target="_blank" rel="noreferrer">Outlook
for iOS</a></div>
<div id="m_-7181965662703677245mail-editor-reference-message-container">
<hr style="display:inline-block;width:98%">
<div id="m_-7181965662703677245divRplyFwdMsg" dir="ltr"><font face="Calibri,
sans-serif"><b>From:</b> Sophie Hey
<a href="mailto:sophie.hey@comlaude.com" target="_blank" rel="noreferrer"><sophie.hey@comlaude.com></a><br>
<b>Sent:</b> Monday, June 12, 2023 5:02 PM<br>
<b>To:</b> Manal Ismail <a href="mailto:manal@tra.gov.eg" target="_blank" rel="noreferrer"><manal@tra.gov.eg></a>; Jeff
Neuman <a href="mailto:jeff@jjnsolutions.com" target="_blank" rel="noreferrer"><jeff@jjnsolutions.com></a>; Mary Wong
<a href="mailto:mary.wong@icann.org" target="_blank" rel="noreferrer"><mary.wong@icann.org></a>;
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer">gnso-gac-closed-generics@icann.org</a>
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer"><gnso-gac-closed-generics@icann.org></a><br>
<b>Subject:</b> RE: Outline of next steps and proposed
agenda for Tuesday session at ICANN77
<div> </div>
</font></div>
<font size="2"><span style="font-size:11pt">
<div>I support Manal's suggestion<br>
<br>
Sophie Hey<br>
Policy Advisor<br>
<br>
+44 (0) 20 7421 8250<br>
252<br>
<br>
<a href="http://comlaude.com" target="_blank" rel="noreferrer">comlaude.com</a><br>
-----Original Message-----<br>
From: gnso-gac-closed-generics
<a href="mailto:gnso-gac-closed-generics-bounces@icann.org" target="_blank" rel="noreferrer"><gnso-gac-closed-generics-bounces@icann.org></a> On
Behalf Of Manal Ismail<br>
Sent: Monday, June 12, 2023 4:59 PM<br>
To: Jeff Neuman <a href="mailto:jeff@jjnsolutions.com" target="_blank" rel="noreferrer"><jeff@jjnsolutions.com></a>; Mary
Wong <a href="mailto:mary.wong@icann.org" target="_blank" rel="noreferrer"><mary.wong@icann.org></a>;
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer">gnso-gac-closed-generics@icann.org</a><br>
Subject: Re: [gnso-gac-closed-generics] Outline of
next steps and proposed agenda for Tuesday session at
ICANN77<br>
<br>
Many thanks Patricio for the good suggestion and
Melissa and Mary for accomodating ..<br>
<br>
<br>
If group participants agree, I suggest that we reverse
the order of the comments, and do not have to
necessarily divide the time equally .. We have already
spoken for the whole session today, and I would like
to see us favoring community input during this session
.. That said, in order to secure enough time for
community feedback during this session, I propose we
start each block by listening to community
interventions, then respond or comment as apporiate ..<br>
<br>
<br>
Thoughts?<br>
<br>
<br>
Kind Regards<br>
<br>
--Manal<br>
<br>
<br>
________________________________<br>
From: gnso-gac-closed-generics
<a href="mailto:gnso-gac-closed-generics-bounces@icann.org" target="_blank" rel="noreferrer"><gnso-gac-closed-generics-bounces@icann.org></a> on
behalf of Jeff Neuman <a href="mailto:jeff@jjnsolutions.com" target="_blank" rel="noreferrer"><jeff@jjnsolutions.com></a><br>
Sent: Monday, June 12, 2023 10:06 PM<br>
To: Mary Wong; <a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer">gnso-gac-closed-generics@icann.org</a><br>
Subject: Re: [gnso-gac-closed-generics] Outline of
next steps and proposed agenda for Tuesday session at
ICANN77<br>
<br>
Mary,<br>
<br>
I guess I agree on agenda. The rest of the email on
what happens next is beyond scope of group.<br>
<br>
Get Outlook for iOS<<a href="https://aka.ms/o0ukef" target="_blank" rel="noreferrer">https://aka.ms/o0ukef</a>><br>
________________________________<br>
From: gnso-gac-closed-generics
<a href="mailto:gnso-gac-closed-generics-bounces@icann.org" target="_blank" rel="noreferrer"><gnso-gac-closed-generics-bounces@icann.org></a> on
behalf of Mary Wong <a href="mailto:mary.wong@icann.org" target="_blank" rel="noreferrer"><mary.wong@icann.org></a><br>
Sent: Monday, June 12, 2023 2:02:48 PM<br>
To: <a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer">gnso-gac-closed-generics@icann.org</a>
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer"><gnso-gac-closed-generics@icann.org></a><br>
Subject: [gnso-gac-closed-generics] Outline of next
steps and proposed agenda for Tuesday session at
ICANN77<br>
<br>
<br>
Dear all,<br>
<br>
<br>
<br>
Based on the questions and discussions at the first
open session held earlier today, and to prepare for
the second open session coming up tomorrow, staff
would like to outline what we understand to be the
next steps for the dialogue work leading up to a Final
Framework. We have started to document next steps on
your public wiki space<<a href="https://community.icann.org/display/GFDOCG/FOR+INPUT%3A+Draft+Framework+for+Closed+Generic+gTLDs" target="_blank" rel="noreferrer">https://community.icann.org/display/GFDOCG/FOR+INPUT%3A+Draft+Framework+for+Closed+Generic+gTLDs</a>>,
and we plan on including this information in the
twice-weekly Community Leadership Digest that the
Policy Development Support team publishes for the
community, up to the suggested closing date of 15 July
2023. We will also coordinate with our colleagues that
support all the different SOAC groups, to ensure that
their members are aware of the invitation to provide
feedback on the Draft Framework.<br>
<br>
<br>
<br>
We have set up an email address where community groups
and individuals can send in their input directly:
<a href="mailto:closed-generics-feedback@icann.org" target="_blank" rel="noreferrer">closed-generics-feedback@icann.org</a><a href="mailto:closed-generics-feedback@icann.org" target="_blank" rel="noreferrer"><mailto:closed-generics-feedback@icann.org></a>.
This is a publicly-archived<<a href="https://mm.icann.org/pipermail/closed-generics-feedback/" target="_blank" rel="noreferrer">https://mm.icann.org/pipermail/closed-generics-feedback/</a>>
mailing list, which means that you and anyone that
wishes to can see the submissions as they come in, in
full. The staff team will ensure that all submissions
are made public via the wiki and, similar to the
support we provide to other community policy-related
efforts, collate the feedback into a single tool to
facilitate your discussions on the input received.<br>
<br>
<br>
<br>
In addition, and to encourage community groups to
submit input, they may send their feedback through
their staff support team.<br>
<br>
<br>
<br>
As these steps mirror those that we follow for more
formal Public Comment proceedings, we hope that this
approach, which also ensures that all feedback is
documented and made public, addresses any concerns
from community members about transparency,
accessibility and their ability to provide feedback on
the Draft Framework.<br>
<br>
<br>
<br>
After your deliberations on a Final Framework
following your review of the community input, our
understanding is that the three groups that are
participating in the dialogue (i.e. the ALAC, GAC and
GNSO Council) will each use their own internal
processes to signal whether they agree with the
proposed approach in the Final Framework. This is
expected to take place in the third quarter of this
calendar year, and will be the final step before
moving ahead with the requisite policy work through a
GNSO Council-chartered process in which the ALAC and
GAC will also be involved. Of course, as noted in the
Draft Framework, if the group does not reach agreement
on a Final Framework, the issue of closed generic
gTLDs will revert to the ICANN Board for a decision on
the matter for the next round.<br>
<br>
<br>
<br>
Finally, please find below the proposed agenda for the
open session tomorrow:<br>
<br>
<br>
<br>
1. Review of the Draft Framework - Melissa Peters
Allgood & Dialogue Participants (80 mins)<br>
<br>
(i) Application (30 mins)<br>
<br>
Participant comments
(15 mins)<br>
<br>
Community Q&A (15
mins)<br>
<br>
(ii) Evaluation (30 mins)<br>
<br>
Participant comments
(15 mins)<br>
<br>
Community Q&A (15
mins)<br>
<br>
(iii) Contracting & Post-Delegation
(20 mins)<br>
<br>
Participant comments
(10 mins)<br>
<br>
Community Q&A (10 mins)<br>
<br>
<br>
<br>
1. Next Steps - Melissa Peters Allgood (5 mins)<br>
<br>
<br>
<br>
Best regards,<br>
<br>
<br>
<br>
Mary (on behalf of Melissa Peters Allgood and the
staff team supporting the facilitated dialogue)
_______________________________________________<br>
gnso-gac-closed-generics mailing list<br>
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer">gnso-gac-closed-generics@icann.org</a><br>
<a href="https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics" target="_blank" rel="noreferrer">https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics</a><br>
<br>
_______________________________________________<br>
By submitting your personal data, you consent to the
processing of your personal data for purposes of
subscribing to this mailing list accordance with the
ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" target="_blank" rel="noreferrer">https://www.icann.org/privacy/policy</a>)
and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" target="_blank" rel="noreferrer">https://www.icann.org/privacy/tos</a>).
You can visit the Mailman link above to change your
membership status or configuration, including
unsubscribing, setting digest-style delivery or
disabling delivery altogether (e.g., for a vacation),
and so on.<br>
________________________________<br>
The contents of this email and any attachments are
confidential to the intended recipient. They may not
be disclosed, used by or copied in any way by anyone
other than the intended recipient. If you have
received this message in error, please return it to
the sender (deleting the body of the email and
attachments in your reply) and immediately and
permanently delete it. Please note that Com Laude
Group Limited (the “Com Laude Group”) does not accept
any responsibility for viruses and it is your
responsibility to scan or otherwise check this email
and any attachments. The Com Laude Group does not
accept liability for statements which are clearly the
sender's own and not made on behalf of the group or
one of its member entities. The Com Laude Group is a
limited company registered in England and Wales with
company number 10689074 and registered office at 28-30
Little Russell Street, London, WC1A 2HN England. The
Com Laude Group includes Nom-IQ Limited t/a Com Laude,
a company registered in England and Wales with company
number 5047655 and registered office at 28-30 Little
Russell Street, London, WC1A 2HN England; Valideus
Limited, a company registered in England and Wales
with company number 6181291 and registered office at
28-30 Little Russell Street, London, WC1A 2HN England;
Demys Limited, a company registered in Scotland with
company number SC197176 and registered office at 15
William Street, South West Lane, Edinburgh, EH3 7LL
Scotland; Consonum, Inc. dba Com Laude USA and
Valideus USA, a corporation incorporated in the State
of Washington and principal office address at Suite
332, Securities Building, 1904 Third Ave, Seattle, WA
98101; Com Laude (Japan) Corporation, a company
registered in Japan with company number 0100-01-190853
and registered office at 1-3-21 Shinkawa, Chuo-ku,
Tokyo, 104-0033, Japan; Com Laude Domain ESP S.L.U., a
company registered in Spain and registered office
address at Calle Barcas 2, 2, Valencia, 46002, Spain.
For further information see
<a href="http://www.comlaude.com/%3Chttps://comlaude.com/%3E" target="_blank" rel="noreferrer">http://www.comlaude.com/<https://comlaude.com/></a><br>
</div>
</span></font></div>
</div>
</div>
<br>
<fieldset></fieldset>
<pre>_______________________________________________
gnso-gac-closed-generics mailing list
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer">gnso-gac-closed-generics@icann.org</a>
<a href="https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics" target="_blank" rel="noreferrer">https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics</a>
_______________________________________________
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" target="_blank" rel="noreferrer">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" target="_blank" rel="noreferrer">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.</pre>
</blockquote>
</div>
_______________________________________________<br>
gnso-gac-closed-generics mailing list<br>
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank" rel="noreferrer">gnso-gac-closed-generics@icann.org</a><br>
<a href="https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics" rel="noreferrer noreferrer" target="_blank">https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics</a><br>
<br>
_______________________________________________<br>
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" rel="noreferrer noreferrer" target="_blank">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" rel="noreferrer noreferrer" target="_blank">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.</blockquote></div>